NCT00781885View on ClinicalTrials.gov

A Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Beraprost sodium modified release

Tablets 60mcg

Trial Locations (6)

3000

Gastuiberg University Hospital, Leuven

8550

UTSW Medical Center, Dallas

15212

Allegheny General Hospital, Pittsburgh

90502

Harbor-UCLA Medical Center, Torrance

Unknown

Universite Libre de Bruxelles, Hospital Erasme, Brussels

Mater Misericordiae University Hospital Ltd., Dublin

Sponsors
All Listed Sponsors
lead

Lung Biotechnology PBC

INDUSTRY

NCT00781885 - A Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH Patients | Biotech Hunter | Biotech Hunter